Expert Interview
Discussing the implications of recent lawsuits filed by branded manufacturers to stop GLP-1 drug compounding.
Ticker(s): NVO, LLYInstitution: New York Law School
- Associate Professor of Law and affiliated faculty at the Innovation Center for Law and Technology. Previously, Prof. Sherkow was a Fellow in the Center for Law and the Biosciences at Stanford Law School and a patent litigator at Gibson, Dunn & Crutcher in New York.
- Has litigated biopharma patents throughout the U.S. and has authored dozens of articles on the topic including the Yale Law Journal, the Stanford Law Review, Science, and Nature.
- Research focuses on how scientific developments, especially in the biosciences, affect patent law and litigation
Are You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- Mar 06, 2026
- Call Time
- 01:00 PM EST
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
